Stay updated on Elunate® Phase IV Study in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.

Latest updates to the Elunate® Phase IV Study in Chinese Patients Clinical Trial page
- Check6 days agoChange DetectedAdded a footer revision note 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'—minor housekeeping changes that do not affect the study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision notice updated from v3.2.0 to v3.3.2; no impact on study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe notice about lapse in government funding and related operating updates was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check56 days agoChange DetectedThe update appears to be a user interface refresh of the study page with reorganized layout and visuals, while core study details such as title, conditions, primary outcomes, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check85 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference7%

- Check92 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, signaling a new release. No changes to core content, prices, or availability are evident.SummaryDifference0.2%

Stay in the know with updates to Elunate® Phase IV Study in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.